Ethyol amifostine cytoprotective agent data

UBS presented results from trials with Ethyol in a variety of indications at the American Society of Clinical Oncology meeting in

Read the full 219 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE